This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Afridi SK, Goadsby PJ (2006) Neuroimaging of migraine. Curr Pain Headache Rep 10(3):221–224
Afridi SK, Matharu MS et al. (2005) A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 128(Pt 4):932-939
Agostoni E, Fumagalli L et al. (2004) Migraine and stroke. Neurol Sci 25 Suppl 3:S 123–125
Ahonen K, Hamalainen ML et al. (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67(7):1135–1140
Airi O, ErkintaloMet al. (2008) Neck muscles’ cross-sectional area in adolescents with and without headache – MRI study. Eur J Pain 12(7):952–959
Airy H (1870) On a distinct form of transient hemiopsia. PhilosTrans R Soc Lond160:247–270
Amberbir A, Medhin G, Alem A, Britton J, Davey G, Venn A (2011) The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema:A longitudinal birth-cohort study. Am J Respir Crit Care Med 183 (2):165-170. Epub 2010 Oct 8. PubMed PMID:20935107
Andersen AR, Friberg HH, Schmidt JF, Hasselbalch SG (1988) Quantitative measurements of cerebral blood flow using SPECT and 99mTc-d, l-HM- PAO compared to xenon-133. J Cereb Blood Flow Metab 8(6):S 69-S 81
Andersen AR, Friberg L, Olsen TS, Olesen J (1988) Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 45(2):154–159
Andreou AP, Goadsby PJ (2011) Topiramate in the treatment of migraine:A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia 31(13):1343–1358
Anttila P, Metsähonkala L et al. (1999) School start and occurrence of headache. Pediatrics 103(6):e80
Anttila P, Metsähonkala L et al. (2000) Predisposing and provoking factors in childhood headache. Headache 40(5):351–356
Anttila P, Metsähonkala L et al. (2001) Comorbidity of other pains in schoolchildren with migraine or nonmigrainous headache. J Pediatr 138(2):176–180
Anttila P, Metsähonkala L et al. (2002) Muscle tenderness in pericranial and neck-shoulder region in children with headache. A controlled study. Cephalalgia 22(5):340–344
Anttila P, Metsähonkala L et al. (2006) Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics 117(6):e1197-e1201
Anttila V, Stefansson H et al. (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42(10):869–873
Aoki K R (2003) Evidence for antinoceptive activity of botulinum toxin type A in pain management. Headache43:S9–S15
Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26(5):785–793
Aretaeus Cappadociae (81131) De causis et signis acutorum et diuturnorum morborum. Liber Primus Oxford, 1723
Aromaa M, Sillanpää ML et al. (1998) Childhood headache at school entry: a controlled clinical study. Neurology 50(6):1729–1736
Aromaa M, Sillanpää ML et al. (1993) Prevalence of frequent headache in young Finnish adults starting a family. Cephalalgia 13(5):330–337
Aromaa M, Sillanpää ML et al. (2000) Pain experience of children with headache and their families: A controlled study. Pediatrics 106(2 Pt 1):270–275
Aromaa M, Rautava P et al. (1996) Prepregnancy headache and the well-being of mother and newborn. Headache 36(7):409–415
Aromaa M, Rautava P et al. (1998) Factors of early life as predictors of headache in children at school entry. Headache 38(1):23–30
Aromaa M, Rautava P et al. (1999) Familial occurrence of headache. Cephalalgia 19 (Suppl 25):49–52
Aurora SK, Dodick DW, Turkel CC et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30(7):793–803
Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group (2007) Botulinum toxin type a prophylactic treatment of episodic migraine:a randomized, double- blind, placebo-controlled exploratory study. Headache 47(4):486–499
Aurora SK (2009) Spectrum of illness: understanding biological patterns and relationships in chronic migraine. Neurology 72(5 Suppl):S 8-S 13
Aurora SK, Dodick DW et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo- controlled phase of the PREEMPT 1 trial. Cephalalgia 30(7):793–803
Bahra A, Matharu MS et al. (2001) Brainstem activation specific to migraine headache. Lancet 357(9261):1016–1017
Barrett CF, Van den Maagdenberg AM et al. (2008) Familial hemiplegic migraine. Adv Genet 63:57–83
Beasley RW, Clayton TO, Crane J, Lai CK, Montefort SR, Mutius E, Stewart AW; and the ISAAC Phase Three Study Group (2011) Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: international study of asthma and allergies in childhood phase three. Am J Respir Crit Care Med 183 (2):171–178. Epub 2010 Aug 13. PubMed PMID:20709817
Benecke R, Heinze A et al. (2011) Botulinum type a toxin complex for the relief of upper back myofascial pain syndrome: How do fixed-location injections compare with trigger point-focused injections? Pain Med
Berilgen MS, Bulut S et al. (2005) Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 25(11):1048–1053
Bernsen HJ, Van de Vlasakker C et al. (1990) Basilar artery migraine stroke. Headache 30(3):142–144
Bertin L, Brion N et al. (1999) A dose-defining study of sumatriptan suppositories in the acute treatment of migraine. Int J Clin Pract 53(8):593–598
Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB (2005) The classification of chronic daily headache in adolescents – a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 45(5):582–589
Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB (2006) Field testing alternative criteria for chronic migraine. Cephalalgia 26(4):477–482
Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71(22):1821–1828
Bigal ME, Rapoport AM et al. (2004) Transformed migraine and medication overuse in a tertiary headache centre – clinical characteristics and treatment outcomes. Cephalalgia 24(6):483–490
Bigal ME, Serrano D et al. (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8):559–566
Bigal ME, Liberman JN et al. (2006) Obesity and migraine: a population study. Neurology 66(4):545–550
Bigal ME, Lipton RB et al. (2009) Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine. Cephalalgia 29(11):1188–1196
Bigal ME, Kurth T et al. (2009) Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72(21):1864–1871
Bigal ME, Sheftell F et al. (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48(9):1286–1293
Bille BS (1962) Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographs comparison between children with migraine and matched controls. Acta Paediatr Suppl 136:1–151
Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (2000) Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123(6):669–676
Bingel U, Evers S, Reister F, Ebinger F, Paulus W (2009) Behandlung der Migra- ne und idiopathischer Kopfschmerzsyndrome in Schwangerschaft und Stillzeit Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 28:896–906
Bingen H von (1180) Liber scivias. Kloster Wiesbaden
Bolay H, Reuter U et al. (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8(2):136–142
Bousser MG (2004) Estrogens, migraine, and stroke. Stroke 35(11 (Suppl 1):2652-2656
Bousser MG, Welch KM (2005) Relation between migraine and stroke. Lancet Neurol 4(9):533–542
Bousser MG, Conard J et al. (2000) Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 20(3):155–156
Bowing G, Zhou J et al. (2010) Differences in Chinese diagnoses for migraine and tension-type headache: an analysis of the German acupuncture trials (GERAC) for headache. Cephalalgia 30(2):224–232
Brennan KC (2011) Turn down the lights!: An irritable occipital cortex in migraine without aura. Neurology 76(3):206–207
Buring JE, Hebert P et al. (1995) Migraine and subsequent risk of stroke in the Physicians’ Health Study. Arch Neurol 52(2):129–134
Cairns B. E. and P. Gazerani (2009) Sex-related differences in pain. Maturitas 63(4):292–296
Caro G, Getsios D et al. (2001) Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis. Cephalalgia 21(1):12–19
Chasman DI, Schürks M et al. (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43(7):695–698
Chernyshev OY, Vein AM et al. (2001) Blood flow velocity and pulsatility index differences in patients with unilateral migraine. Headache 41(7):704-709
Christie S, Göbel H et al. (2003) Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol 49(1):20–29
Cole JW, Kittner SJ (2010) Meta-analysis of results from case control and cohort studies finds that migraine is associated with approximately twice the risk of ischaemic stroke. Evid Based Med 15(6):193–194
Contag SA, Mertz HL et al. (2009) Migraine during pregnancy: is it more than a headache? Nat Rev Neurol 5(8):449–456
Couch JR (2011) Update on chronic daily headache. Curr Treat Options Neurol 13(1):41–55
Cummings M (2009) Modellvorhaben Akupunktur – a summary of the ART, ARC and GERAC trials. Acupunct Med 27(1):26–30
Dahlof C (1997) Would any acute treatment for migraine demonstrate recurrence? Cephalalgia 17 (Suppl 17):17-19; discussion 19-20
Dahlof C (2001) Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials. Cephalalgia 21 (Suppl 1):9-12
Dahlof C (2003) Clinical applications of new therapeutic deliveries in migraine. Neurology 61 ((Suppl 4):S 31-S 34
de Vries B, Frants RR et al. (2009) Molecular genetics of migraine. Hum Genet 126(1):115–132
Denuelle M, Noulloche N et al. (2011) A PET study of photophobia during spontaneous migraine attacks. Neurology 76(3):213–218
Dichgans M, Förderreuther S et al. (1998) The D2 receptor Ncol allele:absence of allelic association with migraine with aura. Neurology 51(3):928
Dichgans M, Herzog J et al. (2005) 1 H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology 64(4):608- 613
Diener HC, Harrer JU (2010) Is migraine a dangerous disease? Neurology 74(8):622–623
Diener HC, Kurth T (2005) Is migraine a risk factor for stroke? Neurology 64(9):1496–1497
Diener HC, Weimar C (2006) Patent foramen ovale, migraine and stroke:no reason to intervene. Nat Clin Pract Cardiovasc Med 3(4):176–177
Diener HC, Tfelt-Hansen P et al. (2001) The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Cephalalgia 21(6):672–679
Diener HC, Eikermann A et al. (2004a) Efficacy of 1,000 mg effervescent ace- tylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 52(1):50–56
Diener HC, Bussone G et al. (2004b) Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24(11):947–954
Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo- controlled parallel group study. Cephalalgia 25 (10):776–787
Diener HC, Kronfeld K, Boewing G et al. (2006) Efficacy of acupuncture for the prophylaxis of migraine:a multicentre randomized controlled clinical trial. Lancet Neurol 5(4):310–316
Diener HC, Agosti R et al. (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6(12):1054–1062
Diener HC, Dodick DW, Aurora SK et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804–814
Diener HC, Dodick DW, Goadsby PJ et al. (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29(10):1021–1027
Diener HC, Dodick DW et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine:results from the double-blind, randomized, placebo- controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804–814
Diener HC, Gaul C et al. (2011a) Integrated headache care. Cephalalgia 31(9):1039–1047
Diener HC, Holle D, Dodick D (2011b) Treatment of chronic migraine. Curr Pain Headache Rep 15 (1):64–69
Dodick DW, Turkel CC, DeGryse RE et al. (2010) OnabotulinumtoxinA for treatment for treatment of chronic migraine:pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50:921–936
Dodick DW, Lipton RB et al. (2008) Predictors of migraine headache recurrences pooled analysis from the eletriptan database. Headache 48(2):184–193
Dowson AJ, MacGregor AE et al. (2002) Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22(2):101–106
Dowson AJ, Massiou H et al. (2002) Almotriptan is an effective and well-tolerated treatment for migraine pain:results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia 22(6):453–461
Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17(4):439–447
Ebers G (1987, 11875) Papyros Ebers – Das hermetische Buch uber die Arznei-mittel der alten Agypter in hieratischer Schrift, 2 Bd, Leipzig
Edmeads J (1999) Management of migraine and epilepsy throughout the reproductive cycle. Neurology 53(4 (Suppl 1):S 1-S 2
Edmeads J, Lainez JM et al. (2001) Potential of the migraine disability assessment (MIDAS ) Questionnaire as a public health initiative and in clinical practice. Neurology 56(6 (Suppl 1):S 29-S 34
Edvinsson L (2009) Migraine: Telcagepant provides new hope for people with migraine. Nat Rev Neurol 5(5):240–242
Edvinsson L, Tfelt-Hansen P (2008) The blood-brain barrier in migraine treatment. Cephalalgia 28(12):1245–1258
Ehrlich P (1956) On immunity with special reference to cell life: Croonian lecture. The collected papers of Paul Ehrlich, Vol. II: Immunology and cancer research. pp 148-192
Eikermann A, Diener HC (2003) Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine. Cephalal- gia 23(5):344–347
Erich Kastner (1959) Gesammelte Schriften:Romane für Kinder. Atrium Verlag, S. 425
Eriksen MK, Thomsen LL et al. (2004) New international classification of migraine with aura (ICHD-2) applied to 362 migraine patients. Eur J Neurol 11(9):583–591
Eriksen MK, Thomsen LL et al. (2005a) Sensitivity and specificity of the new international diagnostic criteria for migraine with aura. J Neurol Neuro- surg Psychiatry 76(2):212–217
Eriksen MK, Thomsen LL et al. (2005b) The Visual Aura Rating Scale (VARS ) for migraine aura diagnosis. Cephalalgia 25(10):801–810
Eriksen MK, Thomsen LL, et al. (2006) Implications of clinical subtypes of migraine with aura. Headache 46(2):286–297
Evers S (2007) Oral rizatriptan – an effective migraine therapy in pediatric patients? Nat Clin Pract Neurol 3(4):196–197
Evers S, Pothmann R et al. (2002) [Treatment of idiopathic headache in childhood – recommendations of the German Migraine and Headache Society (DMKG)]. Schmerz 16(1):48–56
Evers S, Afra J et al. (2006) EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 13(6):560–572
Evers S, May A, Fritsche G et al. (2008) Akuttherapie und Prophylaxe der Migräne. Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft und der Deutschen Gesellschaft für Neurologie. Nervenheilkunde 27:933–949
Evers S, Afra J et al. (2009) EFNS guideline on the drug treatment of migraine#x2014;revised report of an EFNS task force. Eur J Neurol 16(9):968–981
Farquhar H, Stewart A, Mitchell E, Crane J, Eyers S, Weatherall M, Beasley R (2010) The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy 40(1)32–41
Feldhege, F.J., Krauthan, G. (1979) Verhaltenstrainingsprogramm zum Aufbau sozialer Kompetenz. Berlin: Springer.
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment:a meta-analysis of 53 trials. Lancet 358(9294):1668–1675
Ferrari MD (1993) Sumatriptan in the treatment of migraine. Neurology 43 6 (Suppl 3):S43–S47
Ferrari MD (2004) Should we advise patients to treat migraine attacks early? Cephalalgia 24(11):915–917
Ferrari MD (2008) Migraine genetics:a fascinating journey towards improved migraine therapy. Headache 48(5):697–700
Ferrari MD, Roon KI et al. (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358(9294):1668–1675
Fiedler VB, Kettenbach B et al. (1985) Protection by carbocromene and molsidomine against arrhythmias occurring during coronary artery occlusion and reperfusion in dogs. J Cardiovasc Pharmacol 7(5):964–970
Finsterer J, Sommer O et al. (2005) Closure of a patent foramen ovale: effective therapy of migraine and occipital stroke. Int J Neurosci 115(1):119-127
Friberg L et. al. (1994) Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 25:974–979
Friedman BW, Esses D et al. (2008a) A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med 52(4):399–406
Friedman BW, Kapoor A et al. (2008b) The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med 52(6):705–713
Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L (2009a) Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain. 2009 Jan;141(1-2):60-69
Gazerani P, Pedersen NS et al. (2009b) Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. Br J Dermatol 161(4):737–745
Gelfand AA, Fullerton HJ et al. (2010) Child neurology: Migraine with aura in children. Neurology 75(5):e16-e19
Gendolla A (2008) Early treatment in migraine: how strong is the current evidence? Cephalalgia 28 (Suppl 2):28-35
Gerber WD, Miltner W, Birbaumer N, Haag G (1989) Konkordanztherapie. Medienband. Medienband für Therapeuten. München: Röttger
Gerber WD, Diener HC et al. (1991) Responders and non-responders to met- oprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia 11(1):37–45
Gerber WD, Kropp P (1995) ERPs in adult migraineurs. Electroencephalogr Clin Neurophysiol Suppl 44:395–397
Gerber WD, Gerber-von Müller G, Stephani U, Petermann F (2010) Kopfschmerzen bei Kindern und Jugendlichen: Das MIPAS-Family-Programm. Hogrefe, Göttingen
Gerola S, Battistini S et al. (2009) CACNA1 A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology. Clin Chem Lab Med 47(6):783–785
Goadsby PJ (1996) Subcutaneous sumatriptan and the migraine aura. Neurology 46(1):286
Goadsby PJ (1997) How do the currently used prophylactic agents work in migraine? Cephalalgia 17(2):85–92
Goadsby PJ (2002) New directions in migraine research. J Clin Neurosci 9(4):368–373
Goadsby PJ (2003a) Migraine: diagnosis and management. Intern Med J 33(9-10):436–442
Goadsby PJ (2003b) Sporadic hemiplegic migraine:stamp collecting or food for thought? Neurology 60(4):536–537
Goadsby PJ (2005) Is migraine a progressive disorder? Considering the clinical implications of new research data on migraine and brain lesions. Med J Aust 182(3):103–104
Goadsby PJ (2006) Recent advances in the diagnosis and management of migraine. BMJ 332(7532):25–29
Goadsby PJ (2007) Emerging therapies for migraine. Nat Clin Pract Neurol 3(11):610–619
Goadsby PJ (2008) The, Act when Mild’ (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia 28 (Suppl 2):36-41
Goadsby P. J. (2009) Lacrimation, conjunctival injection, nasal symptoms#x2026; cluster headache, migraine and cranial autonomic symptoms in primary headache disorders #x2014; what’s new? J Neurol Neurosurg Psychiatry 80(10):1057–1058
Goadsby PJ (2009) Pathophysiology of migraine. Neurol Clin 27(2):335–360
Goadsby PJ, Fields HL (1998) On the functional anatomy of migraine. Ann Neurol 43(2):272
Goadsby PJ, Olesen J (1996) Diagnosis and management of migraine. BMJ 312(7041):1279–1283
Goadsby PJ, Olesen J (1997) Increasing the options for effective migraine management. Neurology 48(3 (Suppl 3):S 1-S 3
Goadsby PJ, Hargreaves RJ (2000) Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology 55(9 (Suppl 2):S 8-S 14
Goadsby PJ, Ferrari MD et al. (2000) Eletriptan in acute migraine: a double- blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology 54(1):156–163
Goadsby, P. J., J. Goldberg, et al. (2008a) Migraine in pregnancy. BMJ 336(7659):1502-1504
Goadsby PJ, Zanchin G et al. (2008b) Early vs. non-early intervention in acute migraine -,Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 28(4):383–391
Goadsby PJ, Charbit AR et al. (2009) Neurobiology of migraine. Neuroscience 161(2):327–341
Göbel H (1993) Analyse von Kopfschmerzmechanismen durch klinisch- neu- rophysiologische Parameter. Der Schmerz 7 (Suppl 1):4
Göbel H (1994) Paper-pencil tests for retrospective and prospective evaluation of primary headaches on the basis of the IHS criteria. Headache 34(10):564–568
Göbel H (2001) Classification of headaches. Cephalalgia 21(7):770–773
Göbel H (2004) Botulinum toxin in migraine prophylaxis. J Neurol 251 (Suppl 1):I8-I11
Göbel H (2010) Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis. Expert Rev Neurother 10(4):499–506
Göbel H, Heinze A (2011) Botulinum toxin type A in the prophylactic treatment of chronic migraine. Schmerz 25(5):563–570; quiz 571
Göbel H, Heinze A (2011) Chronic migraine and headache by medication overuse. Evolution and revision of classification. Schmerz 25(5):493–500
Göbel H, Heinze A. (2011) The Migraine Intervention Score – a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study. Int J Clin Pract 65(8):879–886
Göbel H, Buschmann P (1998) Schmerztherapie in Deutschland: Status und Perspektiven. Weiterentwicklung der gesetzlichen Krankenversicherung im Bereich der speziellen Schmerztherapie. AOK Schleswig-Holstein, Kiel. S 1–184
Göbel H, Buschmann P (2001) Schmerzen lindern – Kosten senken. Schmerz 15(2):79–80
Göbel H, Cordes P (1990) Zirkadian variation of pain sensitivity in pericranial musculature. Headache 30(7):418–422
Göbel H, Krapat S (1993) Psychological status during migraine attack and interval before and after treatment with a selective 5-HT1-agonist. Headache 33(3):118–120
Göbel H, Schenkl S (1990) Post-lumbar puncture headache: the relation between experimental suprathreshold pain sensitivity and a quasi-experimental clinical pain syndrome. Pain 40(3):267–278
Göbel H, Stadler T (1997) Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine. Drugs 53 (Suppl 2):34-39
Göbel H, Heller O et al. (1988) The correspondence between pain stimulus and pain sensation. Schmerz 2(4):205–211
Göbel H, Klostermann H et al. (1990) Changes in cerebral haemodynamics in cases of post-lumbar puncture headache: a prospective transcranial Doppler ultrasound study. Cephalalgia 10(3):117–122
Göbel H, Schmidt G et al. (1994) Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14(3):228-234; discussion 182
Göbel H, Isler H et al. (1995) Headache classification and the Bible: Was St Paul’s thorn in the flesh migraine? Cephalalgia 15(3):180–181
Göbel H, Stolze H et al. (1996) Easy therapeutical management of sumatrip- tan-induced daily headache. Neurology 47(1):297–298
Göbel H, Ernst M et al. (1992a) Acetylsalicylic acid activates antinociceptive brain-stem reflex activity in headache patients and in healthy subjects. Pain 48(2):187–195
Göbel H, Weigle L et al. (1992b) Pain sensitivity and pain reactivity of pericranial muscles in migraine and tension-type headache. Cephalalgia 12(3):142–151
Göbel H, Petersen-Braun M et al. (1994) The epidemiology of headache in Germany:a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14(2):97–106
Göbel H, Krapat S et al. (1993) Comparison of kontingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan. Headache 33(10):570–572
Göbel H, Krapat S et al. (1994) Exteroceptive suppression of temporalis muscle activity during migraine attack and migraine interval before and after treatment with sumatriptan. Cephalalgia 14(2):143–148
Göbel H, Stolze H, Dworschak M, Soyka D (1995) The N-Methyl-D-Aspartate- (NMDA) antagonist amantadine-sulfat in the prophylactic treatment of migraine:an open pilot study. Cephalalgia 15 (Suppl 14):262
Göbel H, Heinze A et al. (1998a) Effect of operationalized computer diagnosis on the therapeutic results of sumatriptan in general practice. Cephalalgia 18(7):481–486
Göbel H, Lindner V et al. (1998b) Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 51(3):908–911
Göbel H, Heinze A et al. (1999) Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia 19(7):676-683; discussion 626
Göbel H, Winter P et al. (2000) Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clin Ther 22(8):981–989
Göbel H, Heinze A et al. (2001a) Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 91(3):195–199
Göbel H, Heinze A et al. (2001b) Evidence-based medicine:botulinum toxin A in migraine and tension-type headache. J Neurol 248 (Suppl 1):34–38
Göbel H, Heinze A et al. (2001c) Efficacy and tolerability of rizatriptan 10 mg in migraine:experience with 70 527 patient episodes. Headache 41(3):264–270
Göbel H, Heinze A et al. (2004) Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study. Cephalalgia 24(10):888–893
Göbel H, Heinze A et al. (2006) Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome:results from a randomized double-blind placebo- controlled multicentre study. Pain 125(1-2):82–88
Göbel H, Gessner U et al. (2007a) Acetylsalicylic acid in self-medication of migraine. A pharmacy-based observational study. Schmerz 21(1):49–54, 56
Göbel H, Heinze A, Heinze-Kuhn K, Roth A, Rüschmann HH (2007b) Characteristics of patients in headache centers. In: R Jensen, HC Diener, J Olesen (eds) Headache clinics. Organization, patients and treatment. Oxford University Press, p 59-72
Goldstein, J., H. D. Hoffman, et al. (1999) Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia 19(7):684–691
Goncalves DA, Speciali JG et al. (2009) Temporomandibular symptoms, migraine, and chronic daily headaches in the population. Neurology 73(8):645–646
Gowers WR (1907) Subjective sensations of sight and sound, abiotrophy and other lectures. London, Churchill, pp 18–41
Graham JR, Wolf HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737–763
Gu T, Ma XX et al. (2008) Metabolite concentration ratios in thalami of patients with migraine and trigeminal neuralgia measured with 1 H-MRS. Neurol Res 30(3):229–233
Gunner KB, Smith HD (2007) Practice guideline for diagnosis and management of migraine headaches in children and adolescents: part one. J Pediatr Health Care 21(5):327–332
Gunner KB, Smith HD et al. (2008) Practice guideline for diagnosis and management of migraine headaches in children and adolescents: Part two. J Pediatr Health Care 22(1):52–59
Haag G, Diener HC et al. (2011) Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Osterreichische Kopfschmerzgesellschaft (OKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 12(2):201–217
Haake M, Müller HH et al. (2007) German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med 167(17):1892–1898
Haan J, Ferrari MD (2011) Picasso’s migraine: Illusory cubist splitting or illusion? Cephalalgia 31(9):1057–1060
Haan J, Terwindt GM et al. (2008) A review of the genetic relation between migraine and epilepsy. Cephalalgia 28(2):105–113
Hadjikhani N, Sanchez Del Rio M et al. (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98(8):4687–4692
Hadjikhani N, Sanchez Del Rio M, Wu O et al. (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98:4687–4692
Hansen AJ, Lauritzen M (1984) The role of spreading depression in acute brain disorders. An Acad Bras Cienc 56(4):457–479
Hansen JM, Thomsen LL et al. (2011) Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine. Headache 51(4):544–553
Harreveld van A, Fifkova E (1971) Light- and electron-microscopic changes in central nervous tissue after electrophoretic injection of glutamate. Exp Mol Pathol 15(1):61–81
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia:an international journal of headache. 8 (Suppl. 7):1-96
Headache Classification Committee, Olesen J, Bousser MG et al. (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24 (Suppl. 1):1–160
Headache Classification Committee, Olesen J, Bousser MG et al. (2005) Brief report:the international classification of headache disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Ce- phalalgia 25:460–465
Headache Classification Committee, Olesen J, Bousser MG et al. (2006) New appendix criteria open for a broader concept of chronic migraine. Ce- phalalgia 26:742–746
Headache Classification Subcommittee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96
Heinze A, Heinze-Kuhn K et al. (2010) Preventive medication in migraine headache: Individualized clinical pathways. Schmerz 24(1):73–79; quiz 80
Heywood J, Bomhof MA et al. (2000) Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group. Cephalalgia 20(5):470–474
TW HO, Edvinsson L et al. (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6(10):573–582
TW HO, Mannix LK et al. (2008a) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70(16):1304–1312
TW HO, Ferrari MD et al. (2008b) Efficacy and tolerability of MK-0974 (telcage- pant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine:a randomised, placebo- controlled, parallel-treatment trial. Lancet 372(9656):2115–2123
Honkasalo ML, Kaprio J et al. (1993) A population-based survey of headache and migraine in 22,809 adults. Headache 33(8):403–412
Hutson S (2010) Painkiller concerns grow ahead of new guidelines. Nat Med 16(1):10
ladecola C (2002) From CSD to headache: a long and winding road. Nat Med 8(2):110–112
IMS Health (2009) DPM Der pharmazeutische Markt Deutschland. Statistik uber Human-Arzneimittel-Einkaufe offentlicher Apotheken. Frankfürt a. M.
International Headache Genetics Consortium (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42 (10):869–873
Jakubowski M, Silberstein S et al. (2005) Can allodynic migraine patients be identified interictally using a questionnaire? Neurology 65(9):1419–1422
Jarjour IT, O’Brian Smith E (2007) Syncope in migraine: the population-based CAMERA study. Neurology 68(11):878; author reply 878-879
Jolly F (2011) Ober Flimmerskotom und Migräne. Berlin, klin. Wochensch., 1902, XXXIX, 973-976
Jonsson P, Hedenrud T, Linde M (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia
Jonsson P, Hdenrud T et al. (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31(9):1015–1022.
Katsarava Z, Weimar C (2010) Migraine and stroke. J Neurol Sci 299(1-2):42- 44
Katsarava Z, Limmroth V (2006) Is a combination of tramadol and acetaminophen effective for the treatment of acute migraine pain? Nat Clin Pract Neurol 2(7):360–361
Katsarava Z, SchneeweiR S et al. (2004) Incidence and predictors for chro- nicity of headache in patients with episodic migraine. Neurology 62(5):788–790
Katsarava Z, Rabe K et al. (2008) From migraine to stroke. Intern Emerg Med 3 Suppl 1:S 9-16
Katsarava Z, Manack A, Yoon MS (2011) Chronic migraine: classification and comparisons. Cephalalgia 31(5):520–529
Kaube H, Katsarava Z et al. (2002) Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 58(8):1234–1238
Klapper J, Mathew N et al. (2001) Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 41(10):981–984
Klee A (1968) A clinical study of migraine with particular reference to the most severe cases. Copenhagen, Munksgaard
Kloster R, Nestvold K et al. (1992) A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 12(3):169-171; discussion 128
Koppen H, Terwindt GM et al. (2009) No indication for patent foramen ovale closure in migraine. Neth Heart J 17(9):320–321
Koppen H, Palm-Meinders I et al. (2011) The impact of a migraine attack and its after-effects on perceptual organization, attention, and working memory. Cephalalgia 31(14):1419–1427
Kors EE, Maagdenberg AM van den et al. (2002) Calcium channel mutations and migraine. Curr Opin Neurol 15(3):311–316
Kristensen DM, Hass U, Lesné L et al. (2011) Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 26 (1):235–244
Kropp P, Gerber WD (1995) Contingent negative variation during migraine attack and interval:evidence for normalization of slow cortical potentials during the attack. Cephalalgia 15(2):123-128; discussion 178-129.
Kropp P, Kiewitt A. et al. (2000) Reliability and stability of kontingent negative variation. Appl Psychophysiol Biofeedback 25(1):33–41
Kruit MC, Launer LJ et al. (2005) MRI findings in migraine. Rev Neurol (Paris) 161(6-7):661–665
Kruit MC, Launer LJ et al. (2006) Brain stem and cerebellar hyperintense lesions in migraine. Stroke 37(4):1109–1112
Kruit MC, Launer LJ et al. (2009) Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Ce- phalalgia 29(3):351–359
Kruit MC, Buchem MA van et al. (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291(4):427–434
Kruuse C, Thomsen LL et al. (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126 Pt :241–247
Krymchantowski AV, Filho PF et al. (2006) Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia 26(7):871–874
Kurth T (2007) Migraine with aura and ischemic stroke: which additional factors matter? Stroke 38(9):2407–2408
Kurth T (2010) The association of migraine with ischemic stroke. Curr Neurol Neurosci Rep 10(2):133–139
Kurth T, Tzourio C (2010) Is migraine a mirror of the vessel wall? Neurology 75(11):946–947
Kurth T, Diener HC (2006) Current views of the risk of stroke for migraine with and migraine without aura. Curr Pain Headache Rep 10(3):214–220
Kurth T, Slomke MA et al. (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64(6):1020–1026
Kurth T, Schürks M et al. (2009) Migraine frequency and risk of cardiovascular disease in women. Neurology 73(8):581–588
Kurth T, Kase CS et al. (2010) Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ 341:c36-59
Lafreniere RG, Cader MZ, et al. (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16(10):1157–1160
Laimi K, Salminen JJ et al. (2007) Characteristics of neck pain associated with adolescent headache. Cephalalgia 27(11):1244–1254
Laimi K, Metsähonkala L et al. (2006) Outcome of headache frequency in adolescence. Cephalalgia 26(5):604–612
Laimi K, Erkintalo M et al. (2007a) Adolescent disc degeneration – no headache association. Cephalalgia 27(1):14–21
Laimi K, Vahlberg T et al. (2007b) Does neck pain determine the outcome of adolescent headache? Cephalalgia 27(3):244–253
Lampl C, Buzath A et al. (1999) Lamotrigine in the prophylactic treatment of migraine aura – a pilot study. Cephalalgia 19(1):58–63
Lange A, Jakubowski P (1976) Responsible assertive behavior. Champaign, Illinois
Lashley K (1941) Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiatry 46:331-339
Lassen NA, Andersen AR, Friberg L, Paulson OB (1988) The retention of 99mTc-d, l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 8(6):S 13-S 22
Lauritzen, M. (1984) Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2response. J Cereb Blood Flow Metab 4(4):546–554
Lauritzen M, Olesen J (1984) Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 107 Pt :447–461
Lauritzen M, Dreier JP et al. (2011) Clinical relevance of cortical spreading depression in neurological disorders:migraine, malignant stroke, sub- arachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 31(1):17–35
Leão AAP (1944) Spreading depression of activity in cerebral cortex. J Neuro- physiol 7:159–390
Lee TG (1997) Migraine and increased migraine. Neurology 48(5):1472
Leon-Sotomayor LA (1974a) Cardiac migraine – report of twelve cases. Angio- logy 25(3):161–171
Leon-Sotomayor LA (1974b) Posterior fossa tumor mimicking multiple sclerosis. South Med J 67(12):1485–1488
Liberman RP, Mueser KT, Aalto S, Becker DR (2006) Supplementing skills training in supported employment programs. Psychiatr Serv 57419-57420
Liem MK, Oberstein SA et al. (2010) CADASIL and migraine:A narrative review. Cephalalgia 30(11):1284–1289
Liljestrom MR, Jamsa A et al. (2001) Signs and symptoms of temporomandibular disorders in children with different types of headache. Acta Odon- tol Scand 59(6):413–417
Liljestrom MR, Aromaa M et al. (2007) Familial occurrence of signs of temporomandibular disorders in headache children and their mothers. Acta Odontol Scand 65(3):134–140
Liljestrom MR, Le Bell Y et al. (2005) Headache children with temporomandibular disorders have several types of pain and other symptoms. Cephalalgia 25(11):1054–1060
Liljestrom MR, Le Bell Y et al. (2008) Are signs of temporomandibular disorders stable and predictable in adolescents with headache? Cephalalgia 28(6):619–625
Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P (2011) Prevalence and burden of chronic migraine in adolescents: Results of the Chronic daily Headache in Adolescents Study (C-dAS ). Headache 51(5):693-706
Lipton RB (2000) Fair winds and foul headaches:risk factors and triggers of migraine. Neurology 54(2):280–281
Lipton RB (2000) Methodologic issues in acute migraine clinical trials. Neurology 55(9 Suppl 2):S 3-S 7
Lipton RB, Dodick DW (2004) CGRP antagonists in the acute treatment of migraine. Lancet Neurol 3(6):332
Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43(6 Suppl 3):S 6-10
Lipton RB, Scher AI et al. (2002) Migraine in the United States: epidemiology and patterns of health care use. Neurology 58(6):885–894
Lipton RB, Scher AI et al. (2003a) Patterns of health care utilization for migraine in England and in the United States. Neurology 60(3):441–448
Lipton RB, Dodick D et al. (2003b) A self-administered screener for migraine in primary care:The ID Migraine validation study. Neurology 61(3):375–382
Lipton RB, Grosberg B et al. (2010) Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia 30(11):1336–1345
Lipton RB, Dodick DW et al. (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura:a randomised, double- blind, parallel-group, sham-controlled trial. Lancet Neurol 9(4):373–380
Lipton RB, Göbel H et al. (2004) Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63(12):2240–2244
Lipton RB, Kolodner K et al. (2009) Validity and reliability of the Migraine- Treatment Optimization Questionnaire. Cephalalgia 29(7):751–759
Lipton RB, Bigal ME et al. (2004) Double-blind clinical trials of oral triptans vs other classes of acute migraine medication – a review. Cephalalgia 24(5):321–332
Lipton RB, Bigal ME et al. (2004) Migraine practice patterns among neurologists. Neurology 62(11):1926–1931
Lipton RB, Varon SF et al. (2011) OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology 77(15):1465–1472
Lipton RB, Hamelsky SW et al. (2000) Migraine, quality of life, and depression: a population-based case-control study. Neurology 55(5):629–635
Lipton RB, Stewart WF et al. (1997) Burden of migraine:societal costs and therapeutic opportunities. Neurology 48(3 (Suppl 3):S 4-S 9
Lipton RB, Stewart WF et al. (2001) Headache-related disability in the management of migraine. Neurology 56(6 (Suppl 1):S 1-3
Living E (1873) On megrim, sick-headache, and some allied disorders. a contribution to the pathology of nerve-storms. Churchill edition
Lo YL (2010) Headache: migraine, magnetic stimulation and cortical excitability. Nat Rev Neurol 6(8):425–427
Ma Z, Wang SJ et al. (2008) Increased metabolite concentration in migraine rat model by proton MR spectroscopy in vivo and ex vivo. Neurol Sci 29(5):337–342
MacGregor EA (2000) Migraine and female hormones – what factors increase the risk of ischemic stroke? Vasc Med 5(3):133–134
MacGregor EA, Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63(2):351–353
MacGregor EA, Frith A et al. (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67(12):2154–2158
Mack KJ (2011) Can we help patients with chronic migraine? Neurology 76(8):682–683
Maggioni F, Margoni M et al. (2011) Ketogenic diet in migraine treatment: a brief but ancient history. Cephalalgia 31(10):1150–1151
Malpass K (2011) Migraine: Exercise is effective as a nonpharmacological approach to reduce the frequency of migraines. Nat Rev Neurol 7(11):596
Maagdenberg AM van den, Pizzorusso T et al. (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S 218 L mice. Ann Neurol 67(1):85-98
Marcussen RM, Wolff HG (1950) Studies on headache. 1. Effects of carbon dioxide-oxygen mixture given during preheadache phase of the migraine attack. 2. Fürther analysis of the pain mechanisms in headache. Arch Neurol Psychiatry 63:42–51
Marin JC, Goadsby PJ (2010) Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opin Investig Drugs 19(4):555–561
Marino, C (2003) Acute migraine treatment guideline. Ann Intern Med 139(7):603; author reply 603-604
Martin VT, Loder E et al. (2005) Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study. Cephalalgia 25(9):726–734
Mathes RW, Malone KE et al. (2008) Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17(11):3116–3122
Mathes NT (2001a) Antiepileptic drugs in migraine prevention. Headache 41 Suppl 1:S 18-S 24
Mathes NT (2001b) Pathophysiology, epidemiology, and impact of migraine. Clin Cornerstone 4(3):1–17
Mathes NT ,Rapoport A et al. (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41(2):119–128
Mathes NT ,Kailasam J et al. (2004) Clinical recognition of allodynia in migraine. Neurology 63(5):848–852
Mattsson P (2004) Migraine: preventive treatment. Cephalalgia 24(10):908; author reply 908-909
May A, Ashburner J et al. (1999) Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 5(7):836–838
Medicines and Healthcare products Regulatory Agency (2010) Botulinum toxin A (Botox). MHRA 2010:1-117
Meier B (2009) Stroke and migraine: a cardiologist’s headache. Heart 95(7):595–602
Meng J, Ovsepian SV, Wang J et al. (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with antinociceptive potential. J Neurosci 29(15):4981–4992
Merikangas KR, Fenton BT et al. (1997) Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54(4):362–368
Merikangas KR, Dartigues JF et al. (1994) Diagnostic criteria for migraine. A validity study. Neurology 44(6 (Suppl 4):S 11-S 16
Metsähonkala L, Sillanpää M. (1994) Migraine in children – an evaluation of the HIS criteria. Cephalalgia 14(4):285–290
Metsähonkala L, Sillanpää M. , et al. (1997) Headache diary in the diagnosis of childhood migraine. Headache 37(4):240–244
Metsähonkala L, Sillanpää M., et al. (1998) Social environment and headache in 8- to 9-year-old children:a follow-up study. Headache 38(3):222–228
Metsähonkala L, Anttila P et al. (2006) Extracephalic tenderness and pressure pain threshold in children with headache. Eur J Pain 10(7):581–585
Millson D, Frischer M et al. (2000) Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia 20(8):732-737
Monteith TS, Goadsby PJ (2011) Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol 13(1):1–14
Moskowitz MA, Cutrer FM (1997) Attacking migraine headache from beginning to end. Neurology 49(5):1193–1195
Napoli R, Guardasole V et al. (2009) Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 72(24):2111–2114
Netzer C, Freudenberg J et al. (2008a) Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 147B(1):37–41
Netzer C, Freudenberg J et al. (2008b) Replication study of the insulin receptor gene in migraine with aura. Genomics 91(6):503–507
Nightingale S, Ray GS (2010) Paradoxical embolism causing stroke and migraine. J Postgrad Med 56(3):206–208
O’Brien HL, Kabbouche MA et al. (2010) Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol 12(3):178–185
Oksanen A, Metsähonkala L et al. (2005) Leisure activities in adolescents with headache. Acta Paediatr 94(5):609–615
Oksanen A, Metsähonkala L et al. (2006) Strength and mobility of the neck- shoulder region in adolescent headache. Physiother Theory Pract 22(4):163–174
Oksanen A, Poyhonen T et al. (2008) Force production and EMG activity of neck muscles in adolescent headache. Disabil Rehabil 30(3):231–239
Olesen J, Larsen B, Lauritzen M (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9(4):344–352
Olesen J, Tfelt-Hansen P, Welch KMA, Goadsby PJ, Ramadan NM ed. (2006) The Headaches. Lippincott Williams & Wilkins, 3. Edition
Olesen J (1999) Migraine and stroke in young women. Prospective study is needed to determine what clinical practice in migraine should be. BMJ 318(7196):1485–1486
Olesen J (2005) The treatment of acute migraine. Rev Neurol (Paris) 161(6#x2014; 7):679-680
Olesen J (2010) Migraine:A neural pathway for photophobia in migraine. Nat Rev Neurol 6(5):241–242
Olesen J (2011) CGRP in migraine. Cephalalgia 31(5):638
Olesen J, Ashina M (2011) Emerging migraine treatments and drug targets. Trends Pharmacol Sci 32(6):352–359
Olesen J, Diener HC et al. (2004) No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol 11(10):671–677
Olesen J, Bousser MG et al. (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6):742–746
Olesen J, Tfelt-Hansen P et al. (2009) Finding new drug targets for the treatment of migraine attacks. Cephalalgia 29(9):909–920
Olesen J, Burstein R et al. (2009) Origin of pain in migraine:evidence for peripheral sensitisation. Lancet Neurol 8(7):679–690
Olesen J, Steiner T et al. (2009) Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia 29(12):1331- 1336
Olsen TS (1991) Migräne-reliated stroke in childhood. Lancet 337(8756):1546-1547
Pascual J, Vega P et al. (2000) Comparison of rizatriptan 10 mg vs. zolmitrip- tan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia 20(5):455–461
Payne KA, Varon SF et al. (2011) The International Burden of Migraine Study (IBMS ): study design, methodology, and baseline cohort characteristics. Cephalalgia 31(10):1116–1130
Peatfield RC (1999) Migraine. Curr Treat Options Neurol 1(5):450–457
Peroutka SJ (1997) Dopamine and migraine. Neurology 49(3):650–656
Peroutka SJ, Wilhoit T et al. (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology 49(1):201–206
Petermann F, Petermann U (2010) Training mit Jugendlichen. Förderung von Arbeits- und Sozialverhalten. 9. Aufl, Hogrefe, Göttingen
Petri S, Tolle T, Straube A, Pfaffenrath V, Stefenelli U, Ceballos-Baumann A, Dysport Migraine Study Group (2009) Botulinum toxin as preventive treatment for migraine:a randomized double-blind study. Eur Neurol 62(4):204–211
Pezzini A (2010) Dissecting the relation between migraine and stroke: the importance of new phenotyping strategies. Cerebrovasc Dis 30(1):41–42
Pezzini A, Del Zotto E et al. (2010) The migraine-ischemic stroke relation in young adults. Stroke Res Treat 2011:304-921
Pfaffenrath V, Wessely P et al. (1996) Magnesium in the prophylaxis of migraine – a double-blind placebo-controlled study. Cephalalgia 16(6):436–440
Posadzki P, Ernst E (2011) Spinal manipulations for the treatment of migraine: a systematic review of randomized clinical trials. Cephalalgia 31(8):964- 970
Pothmann R, Frankenberg S von, Müller B, Sartory G, Hellmeier W (1994) epidemiology of headache in children and adolescents: Evidence of high prevalence of migraine among girls under 10. Int J Behavior Med 1(1):76–89
Ramadan NM (2005) Targeting therapy for migraine:what to treat? Neurology 64 (10 Suppl 2):S 4-S 8
Raskin NH (1986) Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 36(7):995–997
Raskin NH (2011) Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 77(14):1345
Ravens-Sieberer U, Cieza A (2000) Lebensqualitätsforschung in Deutschland – Forschungsstand, Methoden, Anwendungsbeispiele und Implikationen. In: U Ravens-Sieberer, A Cieza (Hrsg) Lebensqualität und Gesundheits- ökonomie in der Medizin – Konzepte, Methoden, Anwendung (S. 25-50). Ecomed, München
Ravindran MK, Zheng Y et al. (2011) Migraine headaches in chronic fatigue syndrome (CFS ): comparison of two prospective cross-sectional studies. BMC Neurol 11:30
Reed KL, Black SB et al. (2010) Combined occipital and supraorbital neurosti- mulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia 30(3):260–271
Riant F, Ducros A et al. (2010) De novo mutations in ATP1A2 and CACNA1 A are frequent in early-onset sporadic hemiplegic migraine. Neurology 75(11):967–972
Riehl G (2004) Gerac Study of acupuncture. It is not indifferent where the needle is placed. MMW Fortschr Med 146(51-52):18
Robert EA, Emmons ML (2008) Your perfect right: Assertiveness and equality in your life and relationships. Impact, Atascadero
Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10(7):685–692
Rollins G (2002) Migraine sufferers are not seeking nor receiving guideline- based care. Rep Med Guidel Outcomes Res 13(8):7–9
Roth A, Rüschmann H-H (2002) Karrieren chronisch schmerzkranker Patienten in Schleswig-Holstein. Wirkungen einer Modellintervention auf Leistungsinanspruchnahme, Kosten, Arbeit und Sozialsituation sowie Lebensqualität. Gesellschaft für Systemberatung im Gesundheitswesen GSbG, Kiel, S 1-228
Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine:pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10(5):457–470
Sacco, S. and A. Carolei (2011) Is migraine a modifiable risk factor for ischemic stroke? Potentially not. Am J Med124(8):e9; author reply e11
Sacks O (1998) Migräne. Rowohlt, 7. Auflage
Sacks O (2004) The prevalence of migraine in neurologists. Neurology 62(2):342; author reply 342
Salonen R, Saiers J (1999) Sumatriptan is effective in the treatment of menstrual migraine:a review of prospective studies and retrospective analyses. Cephalalgia 19(1):16–19
Sambucus J (1901) Johannes Sambucus (15311584); Icones veterum aliquot ac recentium medicorum philosophorumque
Saper JR (2000) The use of rizatriptan in the treatment of acute, multiple migraine attacks. Neurology 55(9 (Suppl 2):S 15-S 18
Saper JR, Dodick DW et al. (2011) Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 31(3):271–285
Savi L, Omboni S et al. (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain 12(2):219–226
Savi L, Omboni S et al. (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. J Headache Pain 12(6):609–615
Scher AI, Launer LJ (2010) Migraine: migraine with aura increases the risk of stroke. Nat Rev Neurol 6(3):128–129
Schoenen J (2006) Are migraine and headache associated with an increased risk of stroke in women? Nat Clin Pract Neurol 2(2):74–75
Schoenen J, Bulcke J et al. (1994) Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device:comparison with customary treatment in an open, longitudinal study. Cephalalgia 14(1):55–63
Schoenen J, Lenaerts M et al. (1994) High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 14(5):328–329
Scholpp J, Schellenberg R et al. (2004) Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia 24(11):925–933
Schoonman GG, Evers DJ et al. (2007) Is stress a trigger factor for migraine? Psychoneuroendocrinology 32(5):532–538
Schuh-Hofer S, Meisel A et al. (2003) Monozygotic twin sisters suffering from cluster headache and migraine without aura. Neurology 60(11):1864- 1865
Schürks M, Diener HC (2009) Closure of patent foramen ovale in the prevention of migraine: not enough evidence in favor. Nat Clin Pract Neurol 5(1):22–23
Schürks M, Kurth T (2011) Is migraine a predictor for identifying patients at risk of stroke? Expert Rev Neurother 11(5):615–618
Schürks M, Diener HC et al. (2008) Update on the prophylaxis of migraine. Curr Treat Options Neurol 10(1):20–29
Schürks M, Zee RY et al. (2009) ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 72(7):650–656
Schwedt TJ (2008) How long should patients with migraine continue to receive prophylactic topiramate? Nat Clin Pract Neurol 4(6):294–295
Schwedt TJ (2009) The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin 27(2):513–523
Scialli AR, Ang R, Breitmeyer J, Royal MA (2010) A review of the literature on the effects of acetaminophen on pregnancy outcome. Reprod Toxicol 130(4):495–507
Seeburger JL, Taylor FR et al. (2011) Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders. Cephalalgia 31(7):786–796
Shaheen SO, Newson RB, Ring SM, Rose-Zerilli MJ, Holloway JW, Henderson AJ (2010) Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol 126 (6):1141-1148. PubMed PMID:21051083
Shaheen SO, Newson RB, Smith GD, Henderson AJ (2010) Prenatal paracetamol exposure and asthma: fürther evidence against confounding. Int J Epidemiol 39(3):790–794
Shapero G (1999) The difficulties of making rational treatment choices in migraine for the primary care physician. Cephalalgia 19 (Suppl 24):7-10; discussion 10-12
Sheftell FD, Fox AW (2000) Acute migraine treatment outcome measures:a clinician’s view. Cephalalgia 20 (Suppl 2):14-24
Shuhendler AJ, Lee S, Siu M et al. (2009) Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches:a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy 29(7):784–791
Silberstein S (1992) Advances in understanding the pathophysiology of headache. Neurology 42 (Suppl 2):6–10
Silberstein SD(1997) Preventive treatment of migraine: an overview. Cephalalgia 17(2):67–72
Silberstein SD(2000a) Rizatriptan versus usual care in long-term treatment of migraine. Neurology 55(9 (Suppl 2):S 25-28
Silberstein SD (2000b) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (6):754-762
Silberstein SD (2005a) Chronic daily headache. J Am Osteopath Assoc 105(4 Suppl 2):23 S-29 S
Silberstein SD (2005b) Cardiovascular risk factors associated with migraine. Lancet Neurol 4(7):391–392
Silberstein SD (2006) How effective is intensive migraine education provided by migraineurs? Nat Clin Pract Neurol 2(10):526–527
Silberstein SD (2007) Diagnostic testing in episodic migraine: should it include magnetic resonance venography? Nat Clin Pract Neurol 3(5):254–255
Silberstein SD (2008) Treatment recommendations for migraine. Nat Clin Pract Neurol 4(9):482–489
Silberstein SD, Goadsby PJ (2002) Migraine: preventive treatment. Cephalalgia 22(7):491–512
Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near- daily headaches: field trial of revised IHS criteria. Neurology 47(4):871- 875
Silberstein S, Mathew N, Saper J, Jenkins S (2000a) Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40(6):445–450
Silberstein, S. D., P. J. Goadsby, et al. (2000b) Management of migraine:an algorithmic approach. Neurology 55(9 (Suppl 2):S 46-S 52
Silberstein S, Tepper S et al. (2004a) Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. Neurology 62(9):1552- 1557
Silberstein SD, Elkind AH et al. (2004b) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63(2):261–269
Silberstein SD, Olesen J et al. (2005) The International Classification of Headache Disorders, 2nd Edition (ICHD-II) – revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25(6):460-465
Silberstein SD, Göbel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C (2006) Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 26(7):790–800
Silberstein SD, Schoenen J et al. (2009) Tonabersat, a gap-junction modulator:efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia 29 Suppl 2:17-27
Silberstein S, Diener HC et al. (2008a) Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache 48(7):1087-1095
Silberstein S, Saper J et al. (2008b) Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology 70(7):548–555
Silberstein S, Tfelt-Hansen P et al. (2008c) Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 28(5):484–495
Sillanpää M (1976) Prevalence of migraine and other headache in Finnish children starting school. Headache 15(4):288–290
Sillanpää M (1977) Clonidine prophylaxis of childhood migraine and other vascular headache. A double blind study of 57 children. Headache 17(1):28–31
Sillanpää M (1983a) Prevalence of headache in prepuberty. Headache 23:10–14
Sillanpää M (1983b) Changes in the prevalence of migraine and other headaches during the first seven school years. Headache 23:15–19
Sillanpää M, Anttila P (1996) Increasing prevalence of headache in 7-year-old schoolchildren. Headache 36:466–470
Sillanpää M, Aro H (2000) Headache in teenagers: comorbidity and prognosis. Funct Neurol 2000; 15 (Suppl 3):116-121
Sillanpää M, Koponen M (1978) Papaverine in the prophylaxis of migraine and other vascular headache in children. Acta Paediatr Scand 67(2):209–212
Sillanpää M, Koivusilta L (1989) Severe headache and vacation. Headache 29(9):574–578
Sillanpää M, Piekkala P, Kero P (1991) Prevalence of headache at preschool age in an unselected child population. Cephalalgia 11:239–242
Silvestrini M, Bartolini M et al. (2003) Topiramate in the treatment of chronic migraine. Cephalalgia 23(8):820–824
Siniatchkin M, Gerber-von Müller G et al. (2011) Behavioural treatment programme contributes to normalization of kontingent negative variation in children with migraine. Cephalalgia 31(5):562–572
Sjostrand C (2011) Migraine with aura – indication of an increased risk of hemorrhagic stroke in women (Women’s Health Study) and increased risk of overall death in an Icelandic population (Reykjavik Study). Evid Based Med 16(2):60–62
Soon YY, Siow HC et al. (2005) Assessment of migraineurs referred to a specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction. Cephalalgia 25(12):1122–1132
Soyka D, Taneri Z et al. (1988) Flunarizine i. v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study. Cephalalgia 8 Suppl 8:35-40
Spector JT, Kahn SR et al. (2010) Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 123(7):612–624
Sprenger T, Goadsby PJ (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 7:71
Stam AH, Haan J et al. (2009) Migraine and genetic and acquired vasculopa- thies. Cephalalgia 29(9):1006–1017
Stam AH, de Vries B et al. (2010) Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology 74(4):288–294
Stam AH, Louter MA et al. (2011) A long-term follow-up study of 18 patients with sporadic hemiplegic migraine. Cephalalgia 31(2):199–205
Stankewitz A, May A (2011) Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology 77(5):476- 482
Steiner TJ, Diener HC et al. (2003) Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia 23(10):942- 952
Stephenson V (2009) Migraine and risk of stroke. For contraception try lUDs. BMJ 339:b4841
Stevenson J, Simpson J, Bailey V (1988) Research note: recurrent headaches and stomachaches in preschool children. J Child Psychol Psychiatry 29(6):897–900
Stewart WF, Shechter A et al. (1994) Migraine prevalence. A review of population-based studies. Neurology 44(6 (Suppl 4):S 17-S 23
Stokes M, Becker WJ et al. (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA:results from the International Burden of Migraine Study (IBMS ). Headache 51(7):1058-1077
Straube A, Pfaffenrath V et al. (2010) Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia 30(2):207–213
Sun-Edelstein C, Bigal ME, Rapoport AM (2009) Chronic migraine and medication overuse headache:clarifying the current International Headache Society classification criteria. Cephalalgia 29(4):445–452
Taylor FR, Kaniecki RG (2011) Symptomatic treatment of migraine:when to use NSAIDs, triptans, or opiates. Curr Treat Options Neurol 13(1):15–27
Techniker Krankenkasse (2010) Gesundheitsreport. Gesundheitliche Verande- rungen bei Berufstatigen und Arbeitslosen von 2000 bis 2009. Schipplick Winkler, Lubeck
Tfelt-Hansen PC (2010) History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia 30(7) 780–792
Tfelt-Hansen P (2011) Is sustained pain freedom and no adverse events a clinically relevant endpoint in acute migraine treatment? Cephalalgia 31(11):1240
Tfelt-Hansen P, Goadsby PJ (1999) Naratriptan is effective and well tolerated in the acute treatment of migraine. Neurology 52(6):1300–1301
Tfelt-Hansen P, Olesen J (2010) Posterior hypoperfusion in migraine without aura? Cephalalgia 30(8):1018; author reply 1018-1020
Tfelt-Hansen P, Jensen K et al. (1982) Chlormezanone in the treatment of migraine attacks:a double blind comparison with diazepam and placebo. Cephalalgia 2(4):205–210
Tfelt-Hansen, P, Daugaard D et al. (2009) Prednisolone reduces nitric oxide- induced migraine. Eur J Neurol 16(10):1106–1111
Thomsen LL, Olesen J (2004) Sporadic hemiplegic migraine. Cephalalgia 24(12):1016–1023
Tietjen EG (2007a) Migraine and ischaemic heart disease and stroke:potential mechanisms and treatment implications. Cephalalgia 27(8):981–987
Tietjen GE (2007b) Migraine as a systemic disorder. Neurology 68(19):1555-1556
Tietjen GE (2000) The relationship of migraine and stroke. Neuroepidemiolo- gy 19(1):13–19
Tietjen GE, Al-Qasmi MM et al. (2006) Sneddon’s syndrome: another migraine-stroke association? Cephalalgia 26(3):225–232
Tikka-Kleemola P, Kaunisto MA et al. (2009) Genetic association study of endothelin-1 and its receptors EDNRA and EDNRB in migraine with aura. Cephalalgia 29(11):1224–1231
Tikka-Kleemola P, Artto V et al. (2010) A visual migraine aura locus maps to 9q21-q22. Neurology 74(15):1171–1177
Todt U, Dichgans M et al. (2005) Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum Mutat 26(4):315–321
Todt U, Freudenberg J et al. (2006) MTHFR C677 T polymorphism and migraine with aura. Ann Neurol 60(5):621–622; author reply 622–623
Todt U, Freudenberg J et al. (2006) Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura. Neurology 67(9):1707–1709
Todt U, Netzer C et al. (2009) New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 125(3):265–279
Torgovnick J (2011) OnabotulinumtoxinA for the treatment of chronic migraine not quite there. Cephalalgia 31(3):377; author reply 378-379
Ullrich de Muynck R, Ullrich R (1987) Das Assertiveness-Trainings-Programm ATP, Einüben von Selbstvertrauen und sozialer Kompetenz, Teil 1-III. Pfeifer, München
Ulrich V, Gervil M et al. (1999) Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 45(2):242–246
Vahlquist B (1955) Migraine in children. Int Arch Allergy Appl Immunol 7(4-6):348-355
Valade D (2009) Early treatment of acute migraine:new evidence of benefits. Cephalalgia 29 (Suppl 3):15-21
Valade D, Lanteri-Minet M et al. (2010) Clinical determinants of migraine preventive treatment: contribution of SMILE, an observational survey of primary care migraine management in France. Cephalalgia 30(10):1207- 1213
Virtanen R, Aromaa M et al. (2002) Changes in headache prevalence between pre-school and pre-pubertal ages. Cephalalgia 22(3):179–185
Virtanen R, Aromaa M et al. (2007) Changing headache from preschool age to puberty. A controlled study. Cephalalgia 27(4):294–303
Virtanen R, Aromaa M et al. (2009) Prevalence and incidence of headache in adolescent Finnish twins. Headache 49(10):1503–1512
Walker LS, Rosser R (1988) Quality of Life Assessment and Applications. MTP Press/Kluwer, London
Walker SR (1992) Quality of life measurement: an overview. J Royal Sociaty Health 112:265
Wammes-van der Heijden EA, Tijssen CC et al. (2009) Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile. Cephalalgia 29(3):322–330
Wang SJ, Young WB (2011) Needling the pain and comforting the brain: Acupuncture in treatment of chronic migraine. Cephalalgia
Wang SJ, Fuh JL et al. (2009) Migraine and suicidal ideation in adolescents aged 13-15 years. Neurology 72(13):1146–1152
Weiller C, May A, Limmroth V et al. (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1(7):658–660
Weinberger J (2007) Stroke and migraine. Curr Cardiol Rep 9(1):13–19
Weinberger J (2008) Stroke and migraine. Curr Treat Options Cardiovasc Med 10(3):253–260
Welch KM (1994) Relationship of stroke and migraine. Neurology 44(10 (Sup- pl 7):S 33-36
Welch KM (1998) Sumatriptan and migraine-induced stroke: the news is not all bad! J Stroke Cerebrovasc Dis 7(4):227
Welch KM (2003) Contemporary concepts of migraine pathogenesis. Neurology 61(8 (Suppl 4):S 2-S 8
Welch KM (2003) Stroke and migraine – the spectrum of cause and effect. Funct Neurol 18(3):121–126
Welch KM, Levine SR et al. (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39(4):538–541
Welch KM, Levine SR (1990) Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 47(4):458–462
Wenzel KW (2005) Acupuncture: what is the outcome of the Gerac Studies? – Comment on DMW 4/2005. Dtsch Med Wochenschr 130(24):1520; author reply 1520
Wessman M, Terwindt Gm et al. (2007) Migraine: a complex genetic disorder. Lancet Neurol 6(6):521–532
Wettig D (2005) The German acupuncture study (GERAC) – Arthritis-Study: are patients and interviewers previously blinded? Schmerz 19(4):330- 331; author reply 331-332
Wheeler SD (2002) Antiepileptic drug therapy in migraine headache. Curr Treat Options Neurol 4(5):383–394
Willis T (1672) De anima brutorum quae hominis vitalis ac sentitiva est: exerci- tationes duae. Londini, Typis E.F. impensis Ric. Davis, Oxon
Willis T (1667) Pathologiae cerebri, et nervosi generis specimen: in quo agitur de morbis convulsivis et de scorbuto. Oxonii: Excudebat Guil. Hall, impensis Ja. Allestry
Wilper A, Woolhandler S et al. (2010) Impact of insurance status on migraine care in the United States: a population-based study. Neurology 74(15):1178–1183
Wood H (2010) Migraine: Familial migraine with aura is associated with a mutation in the TRESK potassium channel. Nat Rev Neurol 6(12):643
Woodward M (2009) Migraine and the risk of coronary heart disease and ischemic stroke in women. Womens Health (Lond Engl) 5(1):69–77
Young WB (2009) Allodynia as a complication of migraine: background and management. Curr Treat Options Neurol 11(1):3–9
Young WB, Rozen TD (2005) Preventive treatment of migraine: effect on weight. Cephalalgia 25(1):1–11
Zeeberg P, Olesen J et al. (2009) Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria. Cephalalgia 29(2):214–220
Ziegler D, Ford R et al. (1994) Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology 44(3 Pt 1):447-453
Zuckerman B, Stevenson J, Bailey V (1987) Stomachaches and headaches in a community sample of preschool children. Pediatrics 79(5):677–682
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Göbel, H. (2012). Migräne. In: Die Kopfschmerzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20695-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-20695-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20694-8
Online ISBN: 978-3-642-20695-5
eBook Packages: Medicine (German Language)